China Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets

Stock News

2025/11/25

China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) announced that its wholly-owned subsidiary, CR Sike Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. The tablets are indicated as an alternative therapy for hypertension in patients currently taking single-component drugs at doses equivalent to the compound preparation and maintaining well-controlled blood pressure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1146471163"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146471163\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146471163?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-25 16:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146471163","market":"sh","top_or_hot":-1,"title":"China Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets","media":"Stock News","content":"<p>China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) announced that its wholly-owned subsidiary, CR Sike Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. The tablets are indicated as an alternative therapy for hypertension in patients currently taking single-component drugs at doses equivalent to the compound preparation and maintaining well-controlled blood pressure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Double-Crane Pharmaceutical's Subsidiary Obtains Drug Registration Certificate for Bisoprolol Amlodipine Tablets\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-11-25 16:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) announced that its wholly-owned subsidiary, CR Sike Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. The tablets are indicated as an alternative therapy for hypertension in patients currently taking single-component drugs at doses equivalent to the compound preparation and maintaining well-controlled blood pressure.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600062","symbol_name":"華潤雙鶴","start_time":0,"source_url":"","article_id":"1146471163","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146471163","pubTimestamp":1764061116,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) announced that its wholly-owned subsidiary, CR Sike Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600062":"华润双鹤","BK0028":"国家队","BK0175":"白马股","BK0239":"医药制造","BK0185":"二线龙头","EWW":"墨西哥投资指数ETF-iShares MSCI","BK0010":"央企","BK0188":"融资融券"},"translate_title":"华润双鹤药业子公司获得比索洛尔氨氯地平片药品注册证书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600062":1,"MXPmain":1,"EWW":1},"content_text":"China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH) announced that its wholly-owned subsidiary, CR Sike Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate for Bisoprolol Amlodipine Tablets issued by the National Medical Products Administration. The tablets are indicated as an alternative therapy for hypertension in patients currently taking single-component drugs at doses equivalent to the compound preparation and maintaining well-controlled blood pressure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}